In this webinar, Marius Sieverding, Data Scientist, Veramed shares his insights on how best to collaborate in an evolving submission landscape from a Statistical and Clinical perspective. During the Q&A session, Marius is joined by Arthur Allignol, Senior Principal Statistician, Daiichi Sankyo, a member of the PSI HTA special interest group, who provides a unique perspective from the view of the sponsor.
Agenda
- Unveiling the Nuances of EU HTA Process
- Addressing the implications of upcoming changes in EU HTA legislation
- Common Pitfalls and Challenges in Translating between Estimands and PICOs
- Strategies to mitigate risk the consequences of misspecification
- Enhancing Collaboration for Optimal Evidence Generation
- How best to align objectives between regulatory and market access teams
